High-Drug-Loading Mesoporous Silica Nanorods with Reduced Toxicity for Precise Cancer Therapy against Nasopharyngeal Carcinoma

2017 ◽  
Vol 27 (42) ◽  
pp. 1703313 ◽  
Author(s):  
Yuanyuan You ◽  
Lizhen He ◽  
Bin Ma ◽  
Tianfeng Chen
2020 ◽  
Vol 8 (3) ◽  
pp. 949-959 ◽  
Author(s):  
Yuchen Wu ◽  
Shixian Lv ◽  
Yongjuan Li ◽  
Hua He ◽  
Yong Ji ◽  
...  

The introduction of donor-receptor coordination between micelles and drug payloads provides a precise co-delivery strategy for two different chemo-drugs with high drug loading and ROS responsiveness.


RSC Advances ◽  
2019 ◽  
Vol 9 (61) ◽  
pp. 35566-35578 ◽  
Author(s):  
Subhankar Mukhopadhyay ◽  
Hanitrarimalala Veroniaina ◽  
Tadious Chimombe ◽  
Lidong Han ◽  
Wu Zhenghong ◽  
...  

Protean mesoporous silica nanoparticles are propitious candidates over decades for nanoscale drug delivery systems due to their unique characteristics, including changeable pore size, mesoporosity, high drug loading capacity and biodegradability.


2013 ◽  
Vol 42 (24) ◽  
pp. 8918 ◽  
Author(s):  
Baixiang Wang ◽  
Weiyan Meng ◽  
Ming Bi ◽  
Yuxin Ni ◽  
Qing Cai ◽  
...  

2018 ◽  
Vol 166 ◽  
pp. 235-244 ◽  
Author(s):  
Shuo Fang ◽  
Yongpeng Hou ◽  
Longbing Ling ◽  
Danquan Wang ◽  
Muhammad Ismail ◽  
...  

Nanoscale ◽  
2020 ◽  
Vol 12 (46) ◽  
pp. 23607-23619
Author(s):  
Yuna Tong ◽  
Lijuan Zhang ◽  
Rong Gong ◽  
Jianyou Shi ◽  
Lei Zhong ◽  
...  

A renoprotective activity hollow mesoporous silica nanocomposite (HMSN) particle doped with trace cerium oxide has been constructed, which not only has the ability to prevent ROS-associated DN pathogenesis but also has high drug loading capacity.


2020 ◽  
Vol 6 (45) ◽  
pp. eabc1725
Author(s):  
Yinxian Yang ◽  
Bingjun Sun ◽  
Shiyi Zuo ◽  
Ximu Li ◽  
Shuang Zhou ◽  
...  

Rational design of nanoparticulate drug delivery systems (nano-DDS) for efficient cancer therapy is still a challenge, restricted by poor drug loading, poor stability, and poor tumor selectivity. Here, we report that simple insertion of a trisulfide bond can turn doxorubicin homodimeric prodrugs into self-assembled nanoparticles with three benefits: high drug loading (67.24%, w/w), high self-assembly stability, and high tumor selectivity. Compared with disulfide and thioether bonds, the trisulfide bond effectively promotes the self-assembly ability of doxorubicin homodimeric prodrugs, thereby improving the colloidal stability and in vivo fate of prodrug nanoassemblies. The trisulfide bond also shows higher glutathione sensitivity compared to the conventional disulfide bond, and this sensitivity enables efficient tumor-specific drug release. Therefore, trisulfide bond–bridged prodrug nanoassemblies exhibit high selective cytotoxicity on tumor cells compared with normal cells, notably reducing the systemic toxicity of doxorubicin. Our findings provide new insights into the design of advanced redox-sensitive nano-DDS for cancer therapy.


Sign in / Sign up

Export Citation Format

Share Document